DePuy Synthes Acquires CrossRoads® Extremity Systems to Further Strengthen Elective Foot & Ankle Portfolio

Innovative Elective Foot & Ankle Products Will Provide Surgeons with Multiple Options to Address Growing Patient Need

WEST CHESTER, PA – February 10, 2022 – Today, the Johnson & Johnson Medical Devices Companies* announced that DePuy Synthes** has acquired CrossRoads^® Extremity Systems, a Tennessee-based foot and ankle company that provides a broad range of procedure-specific, sterile-packed implants and instrumentation systems cleared for lower extremity indications. Private equity firm HealthpointCapital was the majority investor and worked with the CrossRoads^® team to develop the company into a growth leader in foot and ankle. This acquisition further demonstrates DePuy Synthes’ commitment to driving orthopaedic, podiatric and medtech advancements through both internal and external innovation to deliver industry-leading technology that improves patient lives.

“At DePuy Synthes, we look at innovation with one goal in mind: to bring differentiated solutions to market to address the unmet needs of surgeons and patients around the world,” said Oray Boston***, Worldwide President, DePuy Synthes Trauma, Extremities, Craniomaxillofacial and Animal Health. “Healthy feet are a foundational element of overall good health, and we are thrilled about the acquisition of CrossRoads^® and the opportunity to accelerate meaningful innovation by strengthening our offering for elective foot and ankle procedures, enabling us to provide more comprehensive and leading-edge options to surgeons and patients.”

Elective foot surgeries for conditions like bunions and hammertoes are among fast-growing segments of extremities procedures in orthopaedics and podiatry. In the United States alone, 1 in 4 people suffer from bunions, or hallux valgus, a progressive disorder of the foot in which deformity gradually increases and can eventually compromise desired lifestyle or mobility.¹

CrossRoads^® brings several differentiated products to the DePuy Synthes portfolio, including miniBunion^® 3D, dynaBunion^® 4D and DynaForce^® Staple Compression Plates. The miniBunion^® system is a minimally invasive solution for metatarsal bone osteotomy (a procedure to manage mild to moderate hallux valgus) that reduces the incision size as compared to traditional techniques and aims for less pain and a faster recovery.^{2-6^} The dynaBunion^® lapidus system is an option for lapidus bunionectomy (a procedure to manage moderate to severe hallux valgus) and provides instrumentation and implants to correct bunions in four dimensions through smaller incisions. DynaForce^® staple compression plates combine stability with dynamic continuous compression at the fusion site. Together, these systems offer surgical options to address a wide range of bunion deformities – from mild to severe.

In addition to a robust portfolio of more than 25 products, CrossRoads^® also brings the EcoSMART^® Instrument Service, which provides sterilized, reusable instruments for surgical cases, along with post-surgery instrument recovery and processing, to help reduce waste and inefficiencies in the operating room.

With the acquisition complete, DePuy Synthes is committed to bringing these innovative products to more customers and patients across the United States.

1. Roddy E, Weiya Z, Doherty M. Prevalence and associations of hallux valgus in a primary care population. Arthritis Care & Research 2008 59(6):857-862,
2. Lee M, Walsh J, Smith MM, Ling J, Wines A, Lam P. Hallux Valgus Correction Comparing Percutaneous Chevron/Akin (PECA) and Open Scarf/Akin Osteotomies. Foot Ankle Int. 2017;38(8):838-846.
3. Lai MC, Rikhraj IS, Woo YL, Yeo W, Ng YCS, Koo K. Clinical and radiological outcomes comparing percutaneous chevron-Akin osteotomies vs open scarf-Akin osteotomies for hallux valgus.  Foot Ankle Int. 2018;39(3):311-317. doi:10.1177/1071100717745282
4. Maffulli N, Longo UG, Oliva F, Denaro V, Coppola C. Bosch osteotomy and scarf osteotomy for hallux valgus correction. Orthop Clin North Am. 2009;40(4):515-524. doi:10.1016/j.ocl.2009.06.003
5. Ferreira GF, Borges VQ, Moraes LVM, Stéfani KC. Percutaneous Chevron/Akin (PECA) versus open scarf/Akin (SA) osteotomy treatment for hallux valgus: A systematic review and meta-analysis. PLoS One. 2021;16(2):e0242496.
6. Frigg A, Zaugg S, Maquieira G, Pellegrino A. Stiffness and Range of Motion After Minimally Invasive Chevron-Akin and Open Scarf-Akin Procedures. Foot Ankle Int. 2019;40(5):515-525.

MEDIA CONTACT:
Rebecca Genin
Rgenin1@its.jnj.com

About Johnson & Johnson Medical Devices Companies
At Johnson & Johnson Medical Devices Companies, we are helping people live their best lives. Building on more than a century of expertise, we tackle pressing healthcare challenges, and take bold steps that lead to new standards of care while improving people’s healthcare experiences. In surgery, orthopaedics, vision and interventional solutions, we are helping to save lives and paving the way to a healthier future for everyone, everywhere.

About DePuy Synthes
DePuy Synthes, the Orthopaedics Company of Johnson & Johnson, provides one of the most comprehensive orthopaedics portfolios in the world that helps heal and restore movement for the millions of patients we serve. DePuy Synthes solutions, in specialties including joint reconstruction, trauma, extremities, craniomaxillofacial, spinal surgery and sports medicine, in addition to the VELYS™ Digital Surgery portfolio, are designed to advance patient care while delivering clinical and economic value to health care systems worldwide.

Building on our proud product innovation and legacy of industry firsts, we are reimagining the orthopaedic landscape with new advancements in medical technologies and digital surgery across the entire continuum of care to Keep People Moving today and tomorrow. For more information, visit www.depuysynthes.com.